SPOTLIGHT -
Small Doses: November News
AFib Patients Who Had Cancer Are Less Likely to Fill Their Anticoagulant Prescriptions
Patients with atrial fibrillation who have had cancer are less likely to see a cardiologist and less likely to fill anticoagulant prescriptions.
Novel Study Shows Efficacy of Anticoagulant Treatment in Very Elderly with Nonvalvular Atrial Fibrillation
A new study fills in information gaps on NOAC use in patients age 80 and over.
Telepharmacy Use Soars
More telepharmacies are opening and it appears that they are creating jobs.
FDA Moves to Stem Drug Shortages
The agency is exploring ways to increase vital medication access.
Declining Pharmacy School Enrollment, High Drug Prices, and More News
Small Doses is pharmacy news in a way that works for your busy lifestyle
What Amazon’s PillPack Acquisition Means for Your Pharmacy
Amazon's acquiring of PillPack made headlines, but it might not make as many ripples as you would think.
Small Doses: News for Pharmacists in June
Good News for Health-System Pharmacists
An ASHP survey found that more pharmacists are being hired due to expanding roles.
Multistate Generic Lawsuit Expands and Includes Executives
A multistate antitrust investigation into generic drug pricing has expanded further.
FDA Assists Generic Drugmakers with New Guidances
The FDA is promoting generic competition and issuing new REMS guidance.
Becoming a CDE Can Help Make a Difference
How becoming a certified diabetes educator can help improve lives.
Anticoagulants Linked to Lower Dementia Risk
Oral anticoagulants are associated with a significant reduction in dementia risk for atrial fibrillation patients.
New Resource Educates about Therapies for DVT
A new resource for patients with deep vein thrombosis aims to educate about interventional therapies.
Pharmacists Busted for Prying into Prince’s Medical Records
Three pharmacists were caught trying to access the deceased star’s records just days after his death.
Report: Medicare Biosimilar Changes Could Save Billions
A change in reimbursement policy for biosimilar drugs could save CMS billions.
FDA Promises Easier Generic Drug Applications
The FDA has issued draft guidances that should ease the way for more generic drugs.
Using NOACs Reduces Bleeding Risks
Dual antithrombotic therapy using dabigatran significantly reduces risk of bleeding compared to triple therapy using warfarin.
Newer Anticoagulants May Reduce Intraocular Bleeding
The risk of intraocular bleeding was reduced by one-fifth when using newer anticoagulants versus warfarin in a new study.
CA Drug Pricing Bill Set to Pass Despite Generic Concerns
A California bill aimed at curbing drug prices is about to be signed, despite concerns it will raise generic drug prices.
Generic Pricing Lawsuit Against CVS Dropped; Walgreens Suit Stands
CVS Health executives are pleased that a lawsuit alleging collusion with PBMS on generic drug costs has been withdrawn.
Rivaroxaban Shown to Cut Risk of Cardiovascular Events
Rivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.
Law Reauthorizes FDA Fees and Increases Access to Generics/Biosimilars
Senate passes FDARA overwhelmingly, ahead of September deadline.
Generics Savings Continue, but Work Remains
Generic drugs make up 90% of prescriptions.
Retailers and PBMs Laud Generic/Biosimilar Savings
Savings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.
Why Generic Drug Prices Are Dropping
Pharmacy chains are forcing lower generic prices for their customers.
Generic Cholesterol Meds a Boon for Patients
Two recent generic cholesterol-lowering drugs are helping reduce health-care costs.
Priority Generic Drugs to Get Faster FDA Review
FDA will shorten the review periods for priority generic drugs by two months.
Supreme Court Ruling Raises Biosimilars’ Access
High court ruling should make biosimilars available faster.
AAM Report on Generics Finds High Brand Abandonment Rate
Patients are less like to buy a requested brand name prescription than a generic one.
